The fight against malaria is one of humanity’s most significant public health successes. Great progress was made in malaria control over the last two decades, resulting in a reduction in overall cases and deaths.
Tuberculosis (TB) is one of the world’s leading infectious disease killers, killing over 3,000 people every day. In 2022, TB killed 1.3 million people.
Around the world, communities are powerful leaders in the fight against AIDS. People living with, at risk of, or affected by HIV, are critical to delivering HIV care and prevention programs, identifying and removing human rights-related and gender-re...
In 2021, more than 10 million people fell ill from tuberculosis and 1.6 million people died. Effective vaccines would undoubtedly be the best solution to prevent and potentially eradicate TB. However, no new TB vaccine has been licensed in 100 years...
The Global Fund’s Seventh Replenishment resulted in pledges totaling US$15.7 billion to fight for what counts and protect everyone, everywhere from the deadliest infectious diseases and build a healthier, more equitable world.
The International Monetary Fund, in partnership with the Coalition for Epidemic Preparedness Innovations (CEPI), the Global Fund, and Wellcome Trust, is hosting a virtual press briefing for the publication of the “Building Resilience to Long-term Cov...
Twenty years ago, AIDS, tuberculosis and malaria looked unbeatable. Year after year, the world’s deadliest epidemics were claiming millions of lives with devastating consequences for families and communities around the world, especially in poor count...
World leaders, civil society leaders, CEOs, activists, philanthropists, advocates and people affected by HIV, TB and malaria gathered in Lyon, France in October 2019 to make a decision. Do we step up the fight against these diseases, or do we allow o...
1
The Global Fund uses cookies for anonymized statistics on website use and content performance to help us improve and adapt the website.
To consent to the use of cookies, please click “Accept”. To learn more about your rights and options, please read our Privacy Statement.